최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of Parkinson's Disease, v.10 no.3, 2020년, pp.981 - 991
Nam, Daleum (InAm Neuroscience Research Center, Sanbon Medical Center, College of Medicine, Wonkwang University, Gunposi, Gyeonggido, Republic of Korea) , Lee, Jee-Young (Department of Neurology, Seoul National University Boramae Medical Center, Seoul, Republic of Korea) , Lee, Minhyung (Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea) , Kim, Janghwan (Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea) , Seol, Wongi (InAm Neuroscience Research Center, Sanbon Medical Center, College of Medicine, Wonkwang University, Gunposi, Gyeonggido, Republic of Korea) , Son, Ilhong (InAm Neuroscience Research Center, Sanbon Medical Center, College of Medicine, Wonkwang University, Gunposi, Gyeonggido, Republic of Korea) , Ho, Dong Hwan (InAm Neuroscience Research Center, Sanbon Medical Center, College of Medicine, Wonkwang University, Gunposi, Gyeonggido, Republic of Korea)
초록이 없습니다.
Biomolecules 5 282 Seeking a mechanism for the toxicity of oligomeric α-synuclein Roberts 2015 10.3390/biom5020282
Parkinsonism Relat Disord 10 319 The neuromythology of Parkinson’s disease Calne 2004 10.1016/j.parkreldis.2004.03.006
J Neuropathol Exp Neurol 68 816 Lewy body pathology in normal elderly subjects Markesbery 2009 10.1097/NEN.0b013e3181ac10a7
Cell Tissue Res 373 149 Is Lewy pathology in the human nervous system chiefly an indicator of neuronal protection or of toxicity? Chartier 2018 10.1007/s00441-018-2854-6
Nat Commun 4 2575 Structural and functional characterization of two alpha-synuclein strains Bousset 2013 10.1038/ncomms3575
Brain Pathol 26 410 Alpha-synuclein as a biomarker for Parkinson’s disease Atik 2016 10.1111/bpa.12370
Mol Neurodegener 11 7 Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease Majbour 2016 10.1186/s13024-016-0072-9
Mov Disord 33 1724 alpha-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies van Steenoven 2018 10.1002/mds.111
Parkinsons Dis 2016 14 Blood plasma of patients with Parkinson’s disease increases alpha-synuclein aggregation and neurotoxicity Wang 2016
PLoS One 11 e0151156 Abnormal salivary total and oligomeric alpha-synuclein in Parkinson’s disease Vivacqua 2016 10.1371/journal.pone.0151156
Discov Med 25 57 Urine biomarkers in the early stages of diseases: current status and perspective Jing 2018
Biomed Res Int 2014 8 Increased DJ-1 in urine exosome of Korean males with Parkinson’s disease Ho 2014 10.1155/2014/704678
Parkinsons Dis 2018 9 Oxidized DJ-1 levels in urine samples as a putative biomarker for Parkinson’sdisease Jang 2018
Oncotarget 7 43432 Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer Liu 2016 10.18632/oncotarget.9468
Neurology 84 S7.002 Phosphorylated pS1292 LRRK2 to total LRRK2 concentration ratio in urine exosomes distinguishes LRRK2-PD and idiopathic PD (S7.002) Alcalay 2015 10.1212/WNL.84.14_supplement.S7.002
Int J Stem Cells 12 474 Direct reprogramming to human induced neuronal progenitors from fibroblasts of familial and sporadic Parkinson’s disease patients Lee 2019 10.15283/ijsc19075
PLoS One 13 e0196056 ELISA method to detect alpha-synuclein oligomers in cell and animal models Lassen 2018 10.1371/journal.pone.0196056
Toxicol Lett 233 163 The molecular mechanism of rotenone-induced alpha-synuclein aggregation: emphasizing the role of the calcium/GSK3beta pathway Yuan 2015 10.1016/j.toxlet.2014.11.029
Sci Rep 2 898 Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice Pan-Montojo 2012 10.1038/srep00898
PLoS One 9 e90857 A generic method for design of oligomer-specific antibodies Brännström 2014 10.1371/journal.pone.0090857
Front Oncol 8 362 Urinary markers in bladder cancer: an update Santoni 2018 10.3389/fonc.2018.00362
Mol Psychiatry 18 67 Potential metabolite markers of schizophrenia Yang 2013 10.1038/mp.2011.131
Front CellNeurosci 13 150 Urine organic acids as potential biomarkers for autism-spectrum disorder in Chinese children Chen 2019
Psychol Med 6 649 Urinary dimethyltryptamine and psychiatric symptomatology and classification Rodnight 1976 10.1017/S0033291700018304
Ann Rheum Dis 63 1159 Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases Tektonidou 2004 10.1136/ard.2004.022624
J Alzheimers Dis 65 421 Urine-based biomarkers for Alzheimer’s disease identified through coupling computational and experimental methods Yao 2018 10.3233/JAD-180261
Acta Neuropathol 134 819 Alpha-synuclein oligomers: a new hope Bengoa-Vergniory 2017 10.1007/s00401-017-1755-1
J Biol Chem 279 26846 The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils Zhu 2004 10.1074/jbc.M403129200
Neurochem Res 41 2788 Epigallocatechin Gallate (EGCG) Inhibits alpha-synuclein aggregation: a potential agent for Parkinson’s disease Xu 2016 10.1007/s11064-016-1995-9
Nature 477 107 alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation Bartels 2011 10.1038/nature10324
Exp Mol Med 49 e314 Amplification of distinct α-synuclein fibril conformers through protein misfolding cyclic amplification Jung 2017 10.1038/emm.2017.1
FASEB J 20 419 Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson’s disease El-Agnaf 2006 10.1096/fj.03-1449com
Neuroepidemiology 42 204 Increased risk of Parkinson’s disease in patients with end-stage renal disease: a retrospective cohort study Wang 2014 10.1159/000358921
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.